Stock ECILC EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET
Add to a list
To use this feature you must be a member
Log inSign up

Financials EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret

Equities

ECILC

TRAECILC91E0

Pharmaceuticals

Market Closed - Borsa Istanbul
Other stock markets
 11:09:26 2024-04-26 am EDT 		5-day change 1st Jan Change
51.3 TRY +2.09% Intraday chart for EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret +3.89% +16.70%
Apr. 17 EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,871 2,542 5,112 5,133 22,079 30,124
Enterprise Value (EV) 1 1,334 1,966 4,398 3,821 23,092 30,986
P/E ratio 7.79 x 15.6 x 15.9 x 6.8 x 5.28 x 11 x
Yield 11% 1.97% 0.03% 3.9% 1.27% -
Capitalization / Revenue 2.7 x 2.9 x 5.62 x 4.65 x 12.1 x 4.65 x
EV / Revenue 1.93 x 2.24 x 4.84 x 3.46 x 12.6 x 4.78 x
EV / EBITDA 17.2 x 12.5 x 33.2 x 38.9 x 99.2 x 51.4 x
EV / FCF -65.5 x 14.8 x 105 x 16.8 x -24.9 x -290 x
FCF Yield -1.53% 6.74% 0.95% 5.94% -4.01% -0.34%
Price to Book 0.47 x 0.59 x 0.97 x 0.69 x 1.18 x 0.86 x
Nbr of stocks (in thousands) 685,260 685,260 685,260 685,260 685,260 685,260
Reference price 2 2.730 3.710 7.460 7.490 32.22 43.96
Announcement Date 2/27/19 2/27/20 2/26/21 2/25/22 3/1/23 4/17/24
1TRY in Million2TRY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 692.1 877.1 909.1 1,104 1,831 6,479
EBITDA 1 77.71 157.4 132.6 98.21 232.8 603
EBIT 1 68.24 147.9 123.3 89.29 190.5 197.3
Operating Margin 9.86% 16.86% 13.56% 8.09% 10.4% 3.05%
Earnings before Tax (EBT) 1 295.3 193.1 386 939.5 4,579 3,102
Net income 1 240.1 162.7 322.1 755.1 4,178 2,740
Net margin 34.69% 18.55% 35.43% 68.42% 228.22% 42.28%
EPS 2 0.3504 0.2375 0.4700 1.102 6.097 3.998
Free Cash Flow 1 -20.35 132.5 41.78 226.9 -925.6 -106.8
FCF margin -2.94% 15.11% 4.6% 20.56% -50.56% -1.65%
FCF Conversion (EBITDA) - 84.19% 31.51% 231.05% - -
FCF Conversion (Net income) - 81.44% 12.97% 30.05% - -
Dividend per Share 2 0.3000 0.0730 0.002200 0.2920 0.4100 -
Announcement Date 2/27/19 2/27/20 2/26/21 2/25/22 3/1/23 4/17/24
1TRY in Million2TRY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 1,013 862
Net Cash position 1 537 576 714 1,312 - -
Leverage (Debt/EBITDA) - - - - 4.349 x 1.429 x
Free Cash Flow 1 -20.3 133 41.8 227 -926 -107
ROE (net income / shareholders' equity) 6.42% 3.93% 6.74% 11.9% 30.1% 8.29%
ROA (Net income/ Total Assets) 1.03% 1.99% 1.43% 0.78% 0.71% 0.3%
Assets 1 23,331 8,184 22,593 96,309 584,875 912,367
Book Value Per Share 2 5.830 6.240 7.710 10.80 27.40 50.80
Cash Flow per Share 2 0.9000 0.9800 1.250 1.850 0.8100 2.930
Capex 1 2.07 1.65 2.14 6.49 97.8 600
Capex / Sales 0.3% 0.19% 0.23% 0.59% 5.34% 9.26%
Announcement Date 2/27/19 2/27/20 2/26/21 2/25/22 3/1/23 4/17/24
1TRY in Million2TRY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
51.3 TRY
Average target price
53.5 TRY
Spread / Average Target
+4.29%
Consensus

Sector Other Pharmaceuticals

1st Jan change Capi.
EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET Stock EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret
+16.70% 1.08B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ECILC Stock
  4. Financials EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret